Safety and efficacy of reperfusion therapies in acute ischemic stroke related to left ventricular thrombus: A retrospective cohort study
CONCLUSION: Acute reperfusion therapies seem to be effective in the context of stroke in patients with LVT. However, further studies are needed to support the hypothesis that stroke recurrence might be related to the use of IVT.PMID:38431497 | DOI:10.1016/j.neurol.2023.12.009 (Source: Revue Neurologique)
Source: Revue Neurologique - March 2, 2024 Category: Neurology Authors: P Clottes T Bochaton L Mechtouff L Derex T-H Cho J Fontaine L Rascle Y Berthez ène C Amaz H Thibault C Bergerot N Nighoghossian E Ong Source Type: research

Spreading of motor neuron degeneration in ALS is not so random
Rev Neurol (Paris). 2024 Feb 29:S0035-3787(24)00415-6. doi: 10.1016/j.neurol.2024.02.384. Online ahead of print.NO ABSTRACTPMID:38429156 | DOI:10.1016/j.neurol.2024.02.384 (Source: Revue Neurologique)
Source: Revue Neurologique - March 1, 2024 Category: Neurology Authors: P Corcia P Couratier Source Type: research

A case of de novo bilateral chronic cluster headache responding to calcitonin gene-related peptide antibodies
Rev Neurol (Paris). 2024 Feb 29:S0035-3787(24)00416-8. doi: 10.1016/j.neurol.2023.12.008. Online ahead of print.NO ABSTRACTPMID:38429157 | DOI:10.1016/j.neurol.2023.12.008 (Source: Revue Neurologique)
Source: Revue Neurologique - March 1, 2024 Category: Neurology Authors: S Redon C Hirtz L Quesnel A Donnet Source Type: research

Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient
Rev Neurol (Paris). 2024 Feb 29:S0035-3787(24)00371-0. doi: 10.1016/j.neurol.2023.11.011. Online ahead of print.NO ABSTRACTPMID:38429158 | DOI:10.1016/j.neurol.2023.11.011 (Source: Revue Neurologique)
Source: Revue Neurologique - March 1, 2024 Category: Neurology Authors: M Hay S Leguy V Cahagne N Lassalle E Le Page L Michel Source Type: research

Lessons from genetic studies in Alzheimer disease
Rev Neurol (Paris). 2024 Feb 29:S0035-3787(24)00290-X. doi: 10.1016/j.neurol.2023.12.006. Online ahead of print.ABSTRACTResearch on Alzheimer disease (AD) genetics has provided critical advances to the knowledge of AD pathophysiological mechanisms. The etiology of AD can be divided into monogenic (autosomal dominant inheritance) and complex (multifactorial determinism). In monogenic AD, recent advances mainly concern mutation-associated mechanisms, presymptomatic clinical studies, and the search for modifiers of ages of onset that are still ongoing. In complex AD, genetic factors can be further categorized into three class...
Source: Revue Neurologique - March 1, 2024 Category: Neurology Authors: G Nicolas Source Type: research

Spreading of motor neuron degeneration in ALS is not so random
Rev Neurol (Paris). 2024 Feb 29:S0035-3787(24)00415-6. doi: 10.1016/j.neurol.2024.02.384. Online ahead of print.NO ABSTRACTPMID:38429156 | DOI:10.1016/j.neurol.2024.02.384 (Source: Revue Neurologique)
Source: Revue Neurologique - March 1, 2024 Category: Neurology Authors: P Corcia P Couratier Source Type: research

A case of de novo bilateral chronic cluster headache responding to calcitonin gene-related peptide antibodies
Rev Neurol (Paris). 2024 Feb 29:S0035-3787(24)00416-8. doi: 10.1016/j.neurol.2023.12.008. Online ahead of print.NO ABSTRACTPMID:38429157 | DOI:10.1016/j.neurol.2023.12.008 (Source: Revue Neurologique)
Source: Revue Neurologique - March 1, 2024 Category: Neurology Authors: S Redon C Hirtz L Quesnel A Donnet Source Type: research

Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient
Rev Neurol (Paris). 2024 Feb 29:S0035-3787(24)00371-0. doi: 10.1016/j.neurol.2023.11.011. Online ahead of print.NO ABSTRACTPMID:38429158 | DOI:10.1016/j.neurol.2023.11.011 (Source: Revue Neurologique)
Source: Revue Neurologique - March 1, 2024 Category: Neurology Authors: M Hay S Leguy V Cahagne N Lassalle E Le Page L Michel Source Type: research

Lessons from genetic studies in Alzheimer disease
Rev Neurol (Paris). 2024 Feb 29:S0035-3787(24)00290-X. doi: 10.1016/j.neurol.2023.12.006. Online ahead of print.ABSTRACTResearch on Alzheimer disease (AD) genetics has provided critical advances to the knowledge of AD pathophysiological mechanisms. The etiology of AD can be divided into monogenic (autosomal dominant inheritance) and complex (multifactorial determinism). In monogenic AD, recent advances mainly concern mutation-associated mechanisms, presymptomatic clinical studies, and the search for modifiers of ages of onset that are still ongoing. In complex AD, genetic factors can be further categorized into three class...
Source: Revue Neurologique - March 1, 2024 Category: Neurology Authors: G Nicolas Source Type: research

Prevalence of multiple sclerosis in France in 2021: Data from the French health insurance database
CONCLUSION: MS prevalence in France has increased by ∼30% in the last 10years. This increase is probably linked to population ageing, longer survival of PwMS, and the long observation period. The part attributable to a possible increase in MS risk remains to be determined with incidence studies.PMID:38423846 | DOI:10.1016/j.neurol.2023.12.007 (Source: Revue Neurologique)
Source: Revue Neurologique - February 29, 2024 Category: Neurology Authors: C Pierret M Mainguy E Leray Source Type: research

Étienne Serres (1786-1868), a little-known pioneer of neurology
Rev Neurol (Paris). 2024 Feb 26:S0035-3787(24)00370-9. doi: 10.1016/j.neurol.2023.11.012. Online ahead of print.NO ABSTRACTPMID:38413267 | DOI:10.1016/j.neurol.2023.11.012 (Source: Revue Neurologique)
Source: Revue Neurologique - February 27, 2024 Category: Neurology Authors: O Walusinski Source Type: research

The landscape of drug resistant absence seizures in adolescents and adults: Pathophysiology, electroclinical spectrum and treatment options
Rev Neurol (Paris). 2024 Feb 26:S0035-3787(24)00291-1. doi: 10.1016/j.neurol.2023.11.010. Online ahead of print.ABSTRACTThe persistence of typical absence seizures (AS) in adolescence and adulthood may reduce the quality of life of patients with genetic generalized epilepsies (GGEs). The prevalence of drug resistant AS is probably underestimated in this patient population, and treatment options are relatively scarce. Similarly, atypical absence seizures in developmental and epileptic encephalopathies (DEEs) may be unrecognized, and often persist into adulthood despite improvement of more severe seizures. These two seemingl...
Source: Revue Neurologique - February 27, 2024 Category: Neurology Authors: G Daquin F Bonini Source Type: research